Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.
Public ClinicalTrials.gov record NCT00636116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Comparison of Anavip® and CroFab® in the Treatment of Patients With Crotalinae Envenomation: A Randomized, Prospective, Blinded, Controlled, Comparative, Multicenter Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to establish if F(ab)2 antivenom (Anavip) is safe for crotalinae envenomation. Confirm its effectiveness in preventing the occurrence of delayed coagulopathies and compare the safety and efficacy with Fab antivenom (CroFab) in patients with Crotalinae envenomation.
Study identification
- NCT ID
- NCT00636116
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Interventions
- Crotalinae (pit viper) equine immune F(ab)2 Biological
- Crotalidae Polyvalent Immune Fab, ovine Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Oct 31, 2011
- Completion
- Dec 31, 2011
- Last update posted
- Jan 9, 2012
2008 – 2012
United States locations
- U.S. sites
- 18
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Good Samaritan Medical Center | Phoenix | Arizona | 85006 | — |
| Maricopa Integrated Health System | Phoenix | Arizona | 85008 | — |
| Northwest Medical Center | Phoenix | Arizona | 85741 | — |
| Tucson Medical Center | Tucson | Arizona | 85712 | — |
| University Physicians Hospital | Tucson | Arizona | 85713 | — |
| University Medical Center | Tucson | Arizona | 85721 | — |
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| University of California San Diego | San Diego | California | 92103 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| Florida Poison Information Center | Jacksonsville | Florida | 32209 | — |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | — |
| LSU Health Sciences Center, Lousiana Poison Control Center | Shreveport | Louisiana | 71103 | — |
| The Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| The University of New Mexico Hospital | Albuquerque | New Mexico | 87106 | — |
| Pitt County Memorial Hospital | Greenville | North Carolina | 27834 | — |
| St. Joseph Regional Health Center | Bryan | Texas | 77802 | — |
| West Texas Regional Poison Center at Thomason Hospital | El Paso | Texas | 79905 | — |
| Scott and White Memorial Hospital | Temple | Texas | 76508 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00636116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2012 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00636116 live on ClinicalTrials.gov.